Pharmacokinetics of ampicillin and sulbactam in pregnancy. 1993

A Chamberlain, and S White, and R Bawdon, and S Thomas, and B Larsen
Valley Health Associates, Huntington, West Virginia.

OBJECTIVE This study evaluated the effects pregnancy had on pharmacokinetic parameters of ampicillin and sulbactam. METHODS Twenty-two women undergoing cesarean section for obstetric indications were randomly assigned to receive a single intraoperative dose of either 1 gm of ampicillin intravenously or 1 gm of ampicillin plus 0.5 gm of sulbactam intravenously after umbilical cord clamping. Blood was drawn from an indwelling intravenous catheter at 15, 30, 45, 60, 120, 240, and 360 minutes after infusion of the antibiotic for determination of serum ampicillin and/or sulbactam levels. Pharmacokinetic parameters were determined by fitting data (serum concentrations versus time) to a single-compartment model that provided elimination rate constants, beta-intercept (calculated concentration at 0 minutes), area under the time-versus-concentration curve, half-life of the drug, total body clearance, and volume of distribution. After the examination 6 weeks post partum, each subject was given an additional dose of the drug she had received during cesarean section, and a second pharmacokinetic study was performed and compared with the previous results. RESULTS Pregnancy significantly increased the elimination rate constant, decreased the area under the drug-versus-time curve, shortened the serum half-life, and increased the total body clearance in comparison with these parameters in the nonpregnant state for ampicillin. Sulbactam kinetics were similarly affected, although these changes failed to attain statistical significance. CONCLUSIONS Because pregnancy is associated with more rapid elimination of beta-lactam drugs, physicians treating infections in pregnant or newly parturient women should consider using shorter intervals between antibiotic doses when a range of dosage intervals is under consideration.

UI MeSH Term Description Entries
D007432 Intraoperative Period The period during a surgical operation. Intraoperative Periods,Period, Intraoperative,Periods, Intraoperative
D011184 Postoperative Period The period following a surgical operation. Period, Postoperative,Periods, Postoperative,Postoperative Periods
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002585 Cesarean Section Extraction of the FETUS by means of abdominal HYSTEROTOMY. Abdominal Delivery,Delivery, Abdominal,C-Section (OB),Caesarean Section,Postcesarean Section,Abdominal Deliveries,C Section (OB),C-Sections (OB),Caesarean Sections,Cesarean Sections,Deliveries, Abdominal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000667 Ampicillin Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic. Penicillin, Aminobenzyl,Amcill,Aminobenzylpenicillin,Ampicillin Sodium,Ampicillin Trihydrate,Antibiotic KS-R1,Omnipen,Pentrexyl,Polycillin,Ukapen,Aminobenzyl Penicillin,Antibiotic KS R1,KS-R1, Antibiotic,Sodium, Ampicillin,Trihydrate, Ampicillin
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses
D013407 Sulbactam A beta-lactamase inhibitor with very weak antibacterial action. The compound prevents antibiotic destruction of beta-lactam antibiotics by inhibiting beta-lactamases, thus extending their spectrum activity. Combinations of sulbactam with beta-lactam antibiotics have been used successfully for the therapy of infections caused by organisms resistant to the antibiotic alone. Bétamaze,CP-45899,Combactam,Penicillanic Acid Sulfone,Sulbactam Sodium,CP 45899,CP45899,Sodium, Sulbactam,Sulfone, Penicillanic Acid

Related Publications

A Chamberlain, and S White, and R Bawdon, and S Thomas, and B Larsen
May 1999, Antimicrobial agents and chemotherapy,
A Chamberlain, and S White, and R Bawdon, and S Thomas, and B Larsen
January 1986, Reviews of infectious diseases,
A Chamberlain, and S White, and R Bawdon, and S Thomas, and B Larsen
January 1986, Reviews of infectious diseases,
A Chamberlain, and S White, and R Bawdon, and S Thomas, and B Larsen
January 1990, Yao xue xue bao = Acta pharmaceutica Sinica,
A Chamberlain, and S White, and R Bawdon, and S Thomas, and B Larsen
October 1994, Journal of veterinary pharmacology and therapeutics,
A Chamberlain, and S White, and R Bawdon, and S Thomas, and B Larsen
October 1991, Antimicrobial agents and chemotherapy,
A Chamberlain, and S White, and R Bawdon, and S Thomas, and B Larsen
September 1991, Antimicrobial agents and chemotherapy,
A Chamberlain, and S White, and R Bawdon, and S Thomas, and B Larsen
December 2004, American journal of veterinary research,
A Chamberlain, and S White, and R Bawdon, and S Thomas, and B Larsen
August 2002, Journal of veterinary pharmacology and therapeutics,
A Chamberlain, and S White, and R Bawdon, and S Thomas, and B Larsen
May 1998, International journal of clinical pharmacology and therapeutics,
Copied contents to your clipboard!